Geneva Health Forum Addresses Biotech, Trade, Pandemic Flu 21/04/2010 by Catherine Saez and William New, Intellectual Property Watch Leave a Comment Biotechnology, international trade, and pandemic influenza were among the topics discussed at the outset of this year’s Geneva Health Forum.
Geneva Events Address Public Health Solutions For Developing Countries 20/04/2010 by Kaitlin Mara for Intellectual Property Watch Leave a Comment Public health authorities and observers in Geneva this week are discussing problems and possible solutions to medicines pricing and availability in developing countries. But concerns were raised yesterday about a World Health Organization expert group on medicines access and innovation.
Committee Examines Undue Influence, Coordination In WHO Pandemic Flu Response 15/04/2010 by Kaitlin Mara for Intellectual Property Watch 2 Comments A review of the World Health Organization’s response to the 2009 pandemic influenza outbreak kicked off this week, with firm statements from those involved in the response that they were not unduly influenced by outside stakeholders. Still, serious questions remain about the coordination effort, as a nearly a year after the pandemic was declared developed countries find themselves having to dispose of excess vaccines while poorer countries are reporting they have yet to obtain as many as they need.
UNITAID Patent Pool Budget Approved; Implementation To Begin 13/04/2010 by Kaitlin Mara for Intellectual Property Watch 4 Comments Today, board members of international drug purchasing mechanism UNITAID approved a 2010 budget for a pioneering patent pool initiative.
Risk Of Wrongful Medicines Seizures Seen In EU-Central America Trade Deal 06/04/2010 by David Cronin for Intellectual Property Watch 1 Comment A new accord designed to bolster political and economic ties between the European Union and Central America could result in greater seizures of medicines whenever pharmaceutical companies allege that their patents have been infringed, public health advocates have warned.
在WHO就假冒伪劣药品问题吹风会上观点激烈交锋 03/04/2010 by Kaitlin Mara for Intellectual Property Watch Leave a Comment 世界卫生组织就处理假冒伪劣（conterfeit）药品问题继续开展工作，但是上周晚些时候召开的一个会议暴露出一些方面对该组织的工作方式表示担心。
Débat houleux lors d’une réunion d’information organisée par l’OMS sur les médicaments contrefaits 01/04/2010 by Kaitlin Mara for Intellectual Property Watch 2 Comments Alors que l’Organisation mondiale de la Santé (OMS) continue de travailler sur la question des médicaments contrefaits, une réunion organisée en fin de semaine dernière a révélé des inquiétudes quant à la manière dont ce travail est mené.
Unbiased HIV Patent Pool — A Free-Market, Middle-Income Countries Open Model 01/04/2010 by Intellectual Property Watch 4 Comments Brand name pharmaceutical companies’ concerns about profit losses related to the UNITAID patent pool might undermine access to newer and appropriate HIV medicine formulations in resource-limited settings. A universally agreed strategy to supplement UNITAID plan is therefore needed, writes Daniele Dionisio.
Mordaz intercambio de puntos de vista en la reunión informativa de la OMS sobre medicamentos falsificados 01/04/2010 by Kaitlin Mara for Intellectual Property Watch Leave a Comment La Organización Mundial de la Salud (OMS) continúa trabajando en el tema de los medicamentos falsificados, pero la semana pasada una reunión reveló preocupaciones progresivas sobre la forma de conducir la labor.
Pointed Exchange Of Views At WHO Briefing On Counterfeit Drugs 31/03/2010 by Kaitlin Mara for Intellectual Property Watch 1 Comment Work to address counterfeit medicines continues at the World Health Organization, but a meeting late last week revealed ongoing concerns about the way it is being conducted.